Issues & Trends

CGV and the Private Equity Fund: A Strained Relationship… An Uncomfortable Debt Party [Weekly IB]

MBK and Mirae Asset Fail to Repay Acquisition Financing… CGV Borrows 106.1 Billion Won 333.6 Billion Won in Investment Secured for Overseas Theater Business in 2019… Hong Kong IPO Falls Through Company Decides to Issue 70 Billion Won in Commercial Paper to Cover Investor Debt… Financial Burden Becomes a Reality Share Buyback Also Falls Through… Struggling to Find an Exit Amid $400 Million Sale Conditions

JI YEONG-EUI
2026-11-21 08:10:04
[Edaily Marketin JI YEONG-EUI Reporter] A consortium consisting of private equity fund (PEF) manager MBK Partners and Mirae Asset Securities failed to repay a loan it had received to invest in CJ CGV’s overseas cinema business, forcing CJ CGV to lend 106.1 billion won on their behalf. This occurred because the loan matured while time dragged on—with investors unable to sell their shares and CGV unable to buy them back. CJ CGV, which had effectively acted as a guarantor for the investors’ debt, will issue 70 billion won worth of commercial paper (CP) to raise the funds.
Despite Raising 333.6 Billion Won… “Debt Bill” Following Failed IPO
According to investment banking (IB) industry sources and the Financial Supervisory Service’s electronic disclosure system on the 21st, CJ CGV decided to lend 106.1 billion won after the repayment of a loan taken out by the MBK Partners–Mirae Asset Securities consortium to acquire a stake in the overseas cinema business fell through. This is because investors failed to repay the acquisition financing that matured on the 19th. CJ CGV decided to issue 70 billion won in CP to raise funds.

To understand why CGV is repaying a debt incurred by investors, we must go back to 2019. At that time, CJ CGV raised external capital through CGI Holdings, which consolidated its cinema businesses in Asia, including China, Vietnam, and Indonesia. The deal involved CGI Holdings issuing new shares to raise $286 million (approximately 333.6 billion won at the time) in exchange for a 28.57% stake, which was acquired by a consortium comprising MBK Partners and the private equity (PE) division of Mirae Asset Securities. The investors acquired the stake through a special purpose company (SPC) called Asia Cinema Group (ACG) and financed more than half of the required investment through acquisition financing.

At the time the investment was secured, the situation was favorable, and the interests of all parties aligned. CJ CGV planned to use the secured funds for overseas business expansion, while the investors intended to increase CGI Holdings’ enterprise value and recoup their investment through a listing on the Hong Kong Stock Exchange. Although they had planned to proceed with the listing by June 2023, the unexpected COVID-19 pandemic derailed those plans. As theater operations were severely impacted, the listing plan fell through, and investors were unable to recover their funds.

Subsequently, CJ CGV began to resolve the situation by buying back a portion of the shares held by the investors. In August 2023, it reached an agreement with the investors to extend the listing deadline and provide support for refinancing the acquisition financing, and in October of the following year, it even signed a capital replenishment agreement with the lending company, Felix ACG.

The problem lies with this capital supplementation agreement. It is a contract stipulating that if ACG—the investor’s corporate entity—fails to repay the money borrowed for the stock acquisition on time, CJ CGV would lend the shortfall to the lending company. In essence, the investors had invested in CJ CGV’s overseas operations using their own funds supplemented by loans; when they were unable to recover their investment and thus couldn’t repay their debts, the company that received the investment was left to raise the funds needed to repay the loan. Ultimately, when the acquisition financing matured on the 19th, CJ CGV found itself in a position where it had to fulfill its contractual obligations. The amount CJ CGV agreed to lend to the major shareholder, Felix ACG, is $79.7 million, or approximately 106.1 billion won.
(Photo: Yonhap News)

A Relationship That Doesn’t End with a Loan… The $400 Million Sale Is the Key
From CJ CGV’s perspective, this is no small burden. The loan amount amounts to 16.3% of its consolidated equity of 650.3 billion won as of the end of last year. This amount exceeds the consolidated operating profit of 93.8 billion won earned through the third quarter of this year. Although CJ CGV has already recorded approximately 83.15 billion won in related provisions on its books, the liquidity burden resulting from the actual outflow of funds remains a concern. The 70 billion won raised through the issuance of commercial paper (CP) is also a debt that CJ CGV will have to repay in the future.

Whether the company can recover the funds provided immediately is also a key issue. The loan carries an annual interest rate of 4.6%, and the maturity date is set for February 19, 2026. Under the terms of the agreement, CJ CGV can recover funds by taking over the lender’s senior loan claims against ACG and security interests in CGI Holdings shares. However, analysts suggest that the actual likelihood of recovery will depend on how much value is attributed to the overseas theater business held as collateral.

The process of resolving relationships with investors has also been rocky. Last year, CJ CGV exercised its right of first refusal to purchase the remaining shares held by investors but was unable to bridge the gap in opinions regarding the purchase price. The investors have notified CJ CGV of their intention to exercise their tag-along right. The tag-along right allows investors to demand that not only their own shares but also CJ CGV’s shares be bundled together and sold to a third party.

However, a sale to a third party is also no easy task. Since the price must be higher than the purchase price initially offered by CJ CGV, the investors would need to secure at least $400 million based on the value of their shares if they were to sell CGI Holdings’ entire stake to an external party. This represents a significant decline from 2019, when CGI Holdings’ total enterprise value was estimated at approximately $1 billion during its fundraising round. Nevertheless, given the sluggish performance of its cinema businesses in China and Southeast Asia, analysts say it will be difficult to find a new buyer.

An investment banking industry official stated, “With the IPO having fallen through and it being difficult to either buy back the investors’ stakes or sell the overseas operations outright, CGV likely had no viable option other than extending the maturity of its acquisition financing.” The official added, “It was a burden they took on to buy time, but since a sale remains difficult even now, the bigger issue is how to wind down the investment relationship rather than raising funds.”

Economy

Corporation

IT·Science

Economy

[VC's Pick] Big Money Flows into Smart 'Medical AI and Robotics' Technologies That Replace Human Hands

This week (November 16–20), startups in various fields—including robotics, image analysis, and business platforms—secured investments from venture capital (VC) firms and accelerators (ACs). In particu…
2026-11-21 10:04:03

Corporation

Celltrion Sees Full-Scale Results from Direct Sales in the U.S. … “Projected Operating Profit of 2.4 Trillion Won Next Year”

Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
2026-11-21 06:01:02

IT·Science

Penetrium Bioscience and AprilBio Rally as AriBio-Linked Stocks Diverge [K-Bio Pulse]

South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…
2026-11-21 08:17:02